It is not my spin, it is based on data from the research paper below. The authors analysed the R&D costs of 106 new drugs, obtained from a survey of 10 biopharmaceutical firms.
From https://www.sciencedirect.com/science/article/abs/pii/S0167629616000291?via%3Dihub
That is where the The Johns Hopkins Bloomberg School of Public Health sourced the information for their article from.
Are you able to supply the source for your costs claim?
MSB Trading - 2020, page-2789
-
- There are more pages in this discussion • 20,372 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.010(1.02%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.5¢ | $6.248M | 6.438M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 116040 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |